ImmuneWorks, Inc. Information

View Top Employees from ImmuneWorks, Inc.

ImmuneWorks is a clinical stage biotechnology company with deep expertise in immunology and lung disease. The Company, based in Indianapolis, was founded in 2006, receiving an exclusive license from Indiana University. ImmuneWorks is developing IW001, using an immune modulation approach to treat idiopathic pulmonary fibrosis ("IPF"), an orphan disease indication with significant unmet medical need. ImmuneWorks has completed a Phase 1 trial in IPF patients, which demonstrated safety and evidence of clinical efficacy via oral administration of IW001.

Website	https://www.immuneworks.com
Revenue	$3 million
Employees	2 (0 on RocketReach)
Founded	2006
Address	351 W 10th St, Ste 251, Indianapolis, Indiana 46202, US
Phone	+1 317-278-0205
Technologies	JavaScript , HTML , PHP +194 more (view full list)
Industry	Biotechnology, Pharmaceuticals, Healthcare, Science and Engineering, Therapeutic Devices, Health Care, Drug Manufacturing & Research
Keywords	Lung Disease Treatment, Immunology Research, Immunotherapy, Respiratory Diseases, Clinical Stage Biotechnology, Clinical Trials, Biotechnology, Drug Development, Immune System, Clinical Development, Pharmaceutical Research, Therapeutics, Innovative Therapeutics, New Treatments, Biopharma, Life Sciences, Precision Medicine, Health Technology, Medicine
Competitors	Johnson & Johnson, Roche, Novartis, AbbVie, Merck & Co., Inc., Pfizer, Sanofi, GSK, AstraZeneca, Bristol Myers Squibb +46 more (view full list)
SIC	SIC Code 283 Companies, SIC Code 28 Companies
NAICS	NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies